Kellogg vision scientists are working to find more effective treatments and cures for blinding eye diseases. Read about Kellogg’s innovative research to advance our understanding of the disease processes of diabetic retinopathy, a complication of diabetes that damages the retina and can lead to vision loss and even blindness. You can also learn about Kellogg’s investigations of retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration. The research in this issue is supported by the Kellogg Eye Center Annual Fund.
Discoveries by our vision scientists are aimed at cures and new treatments for eye disease to improve the lives of our patients and people around the world. Read about Kellogg’s innovative research to advance glaucoma treatments and health care delivery, and to probe the relationship between Graves’ disease and thyroid eye disease. The research in this issue is supported by the Kellogg Eye Center Annual Fund.
Barry Hoffman and Mary Ann Schrock-Hoffman moved to Michigan from Pennsylvania in 1982. “When we told our ophthalmologist where we would be living, he said that we were in luck—the University of Michigan had one of the finest eye care programs in the world,” says Mr. Hoffman. Read about Mr. And Mrs. Hoffman’s philanthropic pledge to help clinicians and scientists at the Kellogg Eye Center reach their goals on page 3.
Ann A. Edwards has macular degeneration, a blinding eye disease that causes damage to the macula, the part of the retina that is responsible for sharp central vision. Cutting-edge treatments at the University of Michigan Kellogg Eye Center have changed her life, and her gifts will help ensure scientific advancement continues. Read about Mrs. Edward’s story on page 3.